These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6661471)

  • 1. Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam.
    Lew TY; Tollefson G
    Biol Psychiatry; 1983 Dec; 18(12):1441-6. PubMed ID: 6661471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diazepam in the treatment of tardive dyskinesia. Preliminary observations.
    Singh MM
    Int Pharmacopsychiatry; 1976; 11(4):232-4. PubMed ID: 1010710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theoretical implications of tolerance development in DA, ACh and GABA turnover after neuroleptic chronic treatment.
    Agnati LF; Zini I; Lenzi P; Cortelli P; Battistini N; Bernardi P
    Boll Soc Ital Biol Sper; 1981 Jun; 57(11):1261-6. PubMed ID: 6116494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1130-8. PubMed ID: 17513028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of gabaergic drugs on reserpine-induced oral dyskinesia.
    Peixoto MF; Araujo NP; Silva RH; Castro JP; Fukushiro DF; Faria RR; Zanier-Gomes PH; Medrano WA; Frussa-Filho R; Abílio VC
    Behav Brain Res; 2005 May; 160(1):51-9. PubMed ID: 15836900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant neuroleptic syndrome under metoclopramide and neuroleptics in anuria].
    Krähenbühl S; Raisin J; Herren T
    Schweiz Med Wochenschr; 1993 Jul; 123(26):1359-62. PubMed ID: 8342005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome and dopaminergic blockade.
    Hashimoto F; Sherman CB; Jeffery WH
    Arch Intern Med; 1984 Mar; 144(3):629-30. PubMed ID: 6703834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome: a case report.
    Fekadu A; Wakwoya A
    Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease.
    Burke RE; Fahn S; Mayeux R; Weinberg H; Louis K; Willner JH
    Neurology; 1981 Aug; 31(8):1022-5. PubMed ID: 6115336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe "late" dystonia after neuroleptic anxiolysis with fluspirilene].
    Kappler J; Menges C; Ferbert A; Ebel H
    Nervenarzt; 1994 Jan; 65(1):66-8. PubMed ID: 8145878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive dyskinesia in a nonpsychiatric patient due to short-term use of a neuroleptic/anticholinergic combination drug.
    Chouinard G; Boisvert D; Bradwejn J
    Can Med Assoc J; 1982 Apr; 126(7):821-2, 827. PubMed ID: 6122496
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
    Kulkarni SK; Bishnoi M; Chopra K
    Indian J Exp Biol; 2009 Feb; 47(2):91-7. PubMed ID: 19374163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced hyperthermia in Huntington's disease.
    Gaasbeek D; Naarding P; Stor T; Kremer HP
    J Neurol; 2004 Apr; 251(4):454-7. PubMed ID: 15083292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent alterations in gamma-aminobutyric acid responses of male and ovariectomized rats after chronic benzodiazepine agonist exposure: analysis of gamma-aminobutyric acid-activated chloride influx.
    Wilson MA; Biscardi R
    J Pharmacol Exp Ther; 1993 Aug; 266(2):768-73. PubMed ID: 8394916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative neuroleptic malignant syndrome-like symptoms improved with intravenous diazepam: a case report.
    Kishimoto S; Nakamura K; Arai T; Yukimasa O; Fukami N
    J Anesth; 2013 Oct; 27(5):768-70. PubMed ID: 23553148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pisa syndrome: a report of two cases.
    Yassa R
    Br J Psychiatry; 1985 Jan; 146():93-5. PubMed ID: 3978350
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroleptic malignant syndrome with delayed onset of fever following risperidone administration.
    Norris B; Angeles V; Eisenstein R; Seale JP
    Ann Pharmacother; 2006 Dec; 40(12):2260-4. PubMed ID: 17119106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of combined L-dopa and central anticholinergic in a patient with severe drug-induced parkinsonism and tardive dystonia.
    Looper KJ; Chouinard G
    Can J Psychiatry; 1998 Aug; 43(6):646-7. PubMed ID: 9729698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.